Abstract
We report a 51-year-old woman with known SLE on low dose prednisone, recently started on rituximab, who presents with acute respiratory failure and bilateral air space disease. After an initial treatment with broad spectrum antibiotics for healthcare-associated pneumonia and negative serologic studies, a diagnosis of pneumocystis pneumonia was established using bronchoalveolar lavage. We suggest that rituximab can be an aggravating cause of pneumocystis in patients treated with prednisone.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 134-136 |
| Number of pages | 3 |
| Journal | Respiratory Medicine CME |
| Volume | 2 |
| Issue number | 3 |
| DOIs | |
| State | Published - 2009 |
Keywords
- Pneumocystis pneumonia
- Rituximab
ASJC Scopus subject areas
- Pulmonary and Respiratory Medicine
Fingerprint
Dive into the research topics of 'Acute respiratory failure and diffuse pulmonary infiltrates four weeks after rituximab therapy'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS